icr.ac.uk1d
New treatment target for aggressive leukaemia discovered by disrupting its genome organisation
Researchers have identified a key weakness in acute myeloid leukaemia, offering a promising new strategy to delay the ...
icr.ac.uk5d
“I’m glad to be working on something that makes a difference to people’s lives” – Jessica's cancer research career journey
Dr Jessica May Hislop joined The Institute of Cancer Research as a Bioinformatician in the Houlston Lab in the Genetics and Epidemiology division. Together with her colleagues, she is working towards ...
icr.ac.uk13d
Help more women with ovarian and breast cancer to live longer, better lives
Help women with ovarian and breast cancer live longer and better lives by supporting the Institute of Cancer Research. Donate ...
icr.ac.uk13d
Powerful new therapy doubles progression-free survival in advanced breast cancer
A three-drug combination for aggressive advanced breast cancer doubles the length of time before the cancer progresses, ...
icr.ac.uk14d
More than £5 million secured for the ICR from Cancer Research UK’s RadNet programme to fund work in radiotherapy
Cancer Research UK (CRUK) has awarded The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust a ...
icr.ac.uk15d
ESMO 2024: Routine MRI scans detect cancers in asymptomatic patients with rare genetic condition
A study has found that people with Li-Fraumeni syndrome would benefit from annual whole-body MRI scans to screen for cancers. Findings from the SIGNIFIED study, which investigated the benefits of ...
icr.ac.uk15d
New drug target discovered for aggressive form of prostate cancer
Image: Treated prostate cancer cells. Credit: Johann de Bono, The Institute of Cancer Research, London. Scientists have discovered that a protein linked to prostate cancer is associated with more ...
icr.ac.uk15d
ESMO 2024: More than half of advanced melanoma patients treated with combination immunotherapy survive the disease for at least 10 years
Over half (52 per cent) of people diagnosed with advanced melanoma are now surviving the disease for ten years or more when they receive a combination immunotherapy treatment, according to a study led ...
icr.ac.uk15d
New imaging technique could spot patients with aggressive brain tumours who would benefit from immunotherapy
A new imaging technique could mean patients with aggressive brain tumours benefit from cutting edge immunotherapy treatments, ...
icr.ac.uk16d
Over a decade of abiraterone: the drug that revolutionised advanced prostate cancer care
This Prostate Cancer Awareness Month, we’re celebrating over 10 years since abiraterone was first recommended by NICE in England as a treatment for advanced prostate cancer. Diana Cano, Ichha Khanal, ...
icr.ac.uk17d
Breast and ovarian cancer linked to thousands of new gene variants
Scientists have pinpointed thousands of genetic changes in a gene that may increase a person’s risk of developing breast and ovarian cancer, paving the way for better risk assessment and more ...
icr.ac.uk17d
ICR among best UK universities for commercialisation, partnerships and engaging with the public
Our excellence in working with industry and academia, and in engaging with the wider public has been highlighted in an important analysis. The latest Knowledge Exchange Framework – ‘KEF’ for short – ...